Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.

https://doi.org/10.1182/hematology.2019000018

Published: 2019

Journal Articles

Curing Ph + ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant

Adele K. Fielding

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 24–29.

https://doi.org/10.1182/hematology.2019000010

Published: 2019

Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 218–225.

https://doi.org/10.1182/hematology.2019000357

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Novel immunotherapy approaches to follicular lymphoma

Christopher R. Flowers, John P. Leonard, Loretta J. Nastoupil

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 194–199.

https://doi.org/10.1182/asheducation-2018.1.194

Published: 2018

Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Tania Jain, Mark R. Litzow

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 25–34.

https://doi.org/10.1182/asheducation-2018.1.25

Published: 2018

Journal Articles

Biology of CNS lymphoma and the potential of novel agents

James L. Rubenstein

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 556–564.

https://doi.org/10.1182/asheducation-2017.1.556

Published: 2017

Journal Articles

Progress in adult ALL: incorporation of new agents to frontline treatment

Jessica Leonard, Wendy Stock

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 28–36.

https://doi.org/10.1182/asheducation-2017.1.28

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Checkpoint inhibition and cellular immunotherapy in lymphoma

Premal Lulla, Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 390–396.

https://doi.org/10.1182/asheducation-2016.1.390

Published: 2016

Journal Articles

Novel agents in chronic lymphocytic leukemia

Nicole Lamanna, Susan O’Brien

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 137–145.

https://doi.org/10.1182/asheducation-2016.1.137

Published: 2016

Journal Articles

Cellular and vaccine immunotherapy for multiple myeloma

Alfred L. Garfall, Edward A. Stadtmauer

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 521–527.

https://doi.org/10.1182/asheducation-2016.1.521

Published: 2016

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

Journal Articles

Antigen-specific immunotherapies for acute myeloid leukemia

Sarah A. Buckley, Roland B. Walter

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 584–595.

https://doi.org/10.1182/asheducation-2015.1.584

Published: 2015

Journal Articles

Management of prolymphocytic leukemia

Claire Dearden

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.

https://doi.org/10.1182/asheducation-2015.1.361

Published: 2015

Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.

https://doi.org/10.1182/asheducation-2014.1.559

Published: 2014

Journal Articles

Cytotoxic T lymphocytes for leukemia and lymphoma

Catherine M. Bollard, A. John Barrett

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 565–569.

https://doi.org/10.1182/asheducation-2014.1.565

Published: 2014

Journal Articles

Immunotherapeutic strategies including transplantation: eradication of disease

John G. Gribben, John C. Riches

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 151–157.

https://doi.org/10.1182/asheducation-2013.1.151

Published: 2013

NARROW

Mechanisms of and approaches to overcoming resistance to immunotherapy

Curing Ph + ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant

Opportunities for immunotherapy in childhood acute myeloid leukemia

Myeloma: next generation immunotherapy

Moving immunotherapy into the front line in ALL

Antibody-based therapies in patients with acute lymphoblastic leukemia

Novel immunotherapy approaches to follicular lymphoma

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Biology of CNS lymphoma and the potential of novel agents

Progress in adult ALL: incorporation of new agents to frontline treatment

Graft versus tumor effects and why people relapse

Checkpoint inhibition and cellular immunotherapy in lymphoma

Novel agents in chronic lymphocytic leukemia

Cellular and vaccine immunotherapy for multiple myeloma

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Antigen-specific immunotherapies for acute myeloid leukemia

Management of prolymphocytic leukemia

Chimeric antigen receptor T-cell therapy for ALL

Cytotoxic T lymphocytes for leukemia and lymphoma

Immunotherapeutic strategies including transplantation: eradication of disease

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only